Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
International Reviews of Immunology|July 19, 2012
The use of agonistic anti-CD40 therapy in treatments for cancerAndrea Khong, Delia J Nelson, Anna K Nowak, et al.
Journal of Virology|November 1, 1983
Major polypeptide of duck hepatitis B surface antigen particlesP L Marion, S S Knight, M A Feitelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1980
A virus in Beechey ground squirrels that is related to hepatitis B virus of humansP L Marion, L S Oshiro, D C Regnery, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 9, 2013
Agonistic anti-CD40 antibody therapy is effective against postoperative cancer recurrence and metastasis in a murine tumor modelAndrea Khong, Matthew D Brown, Justin B Vivian, et al.
The American Journal of Medicine|July 20, 1982
Preliminary studies of acyclovir in chronic hepatitis BC I Smith, G H Scullard, P B Gregory, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 25, 2016
Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkersJenette Creaney, Ian M Dick, A W Bill Musk, et al.
The European Respiratory Journal|March 3, 2009
Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cellsC Jackaman, S Cornwall, A M Lew, et al.
European Journal of Immunology|April 8, 2010
CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumorAlison M McDonnell, Amy C Prosser, Ivonne van Bruggen, et al.
Hepatology (Baltimore, Md.)|July 1, 1987
Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geeseP L Marion, J M Cullen, R R Azcárraga, et al.
Pageof 20